Please login to the form below

Not currently logged in
Email:
Password:

ABPI/ BIA relocate together

The UK's Association of the British Pharmaceutical Industry and the BioIndustry Association are to relocate to shared offices in London by the end of May

The UK's Association of the British Pharmaceutical Industry (ABPI) and the BioIndustry Association (BIA) are to relocate to shared offices in the Victoria region of London by the end of May.

The bodies, each representing its respective area of life sciences, will remain independent organisations, although the move will 'faciliate more effective joint working on cross-industry issues' according to a shared statement.

Announcing the move, Dr Richard Barker, director general of the ABPI, commented on increased collaborative efforts with the BIA since the establishment of the UK Office for Life Sciences in April 2009 to address key issues affecting the pharmaceutical, medical biotech and devices sectors.

He said: "Our organisations have been able to operate more strategically, and more effectively, by representing the life sciences sector with one voice, alongside the ABHI [Association of British Healthcare Industries] and BIVDA [British In Vitro Diagnostics Association]. This move strengthens a joint determination that the UK remain a great place to invest and do business in life sciences."

Nigel Gaymond, chief executive of the BIA, also championed the decision: "The UK has exceptional strengths in life sciences. Establishing a central venue where those with an interest in life sciences can access the combined expertise of the BIA and ABPI will enable us to highlight more effectively all that the UK has to offer."

16th May 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Jet Off with Maloff Protect

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...

Infographics